Natural products remodel cancer-associated fibroblasts in desmoplastic tumors

Rujing Chen1, Leaf Huang2, Kaili Hu1

  • 1Murad Research Center for Modernized Chinese Medicine, Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.

Insights

Natural products show promise in overcoming therapeutic resistance in desmoplastic tumors by targeting cancer-associated fibroblasts (CAFs). This approach enhances chemotherapy and nanomedicine delivery for improved cancer treatment outcomes.

Area of Science:

  • Oncology
  • Pharmacology
  • Biochemistry

Background:

  • Desmoplastic tumors exhibit significant stromal content and extracellular matrix, leading to therapeutic resistance.
  • Current treatments for desmoplastic tumors are often insufficient for complete eradication.
  • Cancer-associated fibroblasts (CAFs) are the predominant stromal cell type in these tumors.

Purpose of the Study:

  • To review recent advancements in targeting CAFs within desmoplastic tumors.
  • To explore the potential of natural products in modulating CAFs for cancer therapy.
  • To highlight natural products' role in enhancing conventional treatments for desmoplastic tumors.

Main Methods:

  • Literature review of studies on natural products and CAFs in desmoplastic tumors.
  • Analysis of mechanisms by which natural products affect CAFs.
  • Evaluation of improved drug delivery and therapeutic efficacy.

Main Results:

  • Natural products can modulate CAFs, a key component of the tumor stroma.
  • Targeting CAFs with natural products improves chemotherapy efficacy.
  • Natural products facilitate enhanced delivery of nanomedicines to desmoplastic tumor cells.

Conclusions:

  • Natural products offer a promising strategy for overcoming therapeutic resistance in desmoplastic tumors.
  • Targeting CAFs with natural products presents a viable approach for enhancing cancer treatment.
  • Further research into natural product-CAF interactions could lead to novel therapeutic interventions.